Literature DB >> 20179334

Structure of the unbound form of HIV-1 subtype A protease: comparison with unbound forms of proteases from other HIV subtypes.

Arthur H Robbins1, Roxana M Coman, Edith Bracho-Sanchez, Marty A Fernandez, C Taylor Gilliland, Mi Li, Mavis Agbandje-McKenna, Alexander Wlodawer, Ben M Dunn, Robert McKenna.   

Abstract

The crystal structure of the unbound form of HIV-1 subtype A protease (PR) has been determined to 1.7 A resolution and refined as a homodimer in the hexagonal space group P6(1) to an R(cryst) of 20.5%. The structure is similar in overall shape and fold to the previously determined subtype B, C and F PRs. The major differences lie in the conformation of the flap region. The flaps in the crystal structures of the unbound subtype B and C PRs, which were crystallized in tetragonal space groups, are either semi-open or wide open. In the present structure of subtype A PR the flaps are found in the closed position, a conformation that would be more anticipated in the structure of HIV protease complexed with an inhibitor. The amino-acid differences between the subtypes and their respective crystal space groups are discussed in terms of the differences in the flap conformations.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20179334      PMCID: PMC2827345          DOI: 10.1107/S0907444909054298

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  58 in total

1.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  Effects of remote mutation on the autolysis of HIV-1 PR: X-ray and NMR investigations.

Authors:  Mukesh Kumar; K K Kannan; M V Hosur; Neel S Bhavesh; Amarnath Chatterjee; Rohit Mittal; R V Hosur
Journal:  Biochem Biophys Res Commun       Date:  2002-06-07       Impact factor: 3.575

Review 3.  Protease inhibition in African subtypes of HIV-1.

Authors:  Adrián Velázquez-Campoy; Sonia Vega; Erin Fleming; Usman Bacha; Yasien Sayed; Heini W Dirr; Ernesto Freire
Journal:  AIDS Rev       Date:  2003 Jul-Sep       Impact factor: 2.500

4.  "Wide-open" 1.3 A structure of a multidrug-resistant HIV-1 protease as a drug target.

Authors:  Philip Martin; John F Vickrey; Gheorghe Proteasa; Yurytzy L Jimenez; Zdzislaw Wawrzak; Mark A Winters; Thomas C Merigan; Ladislau C Kovari
Journal:  Structure       Date:  2005-12       Impact factor: 5.006

Review 5.  Role of genetic diversity amongst HIV-1 non-B subtypes in drug resistance: a systematic review of virologic and biochemical evidence.

Authors:  Jorge L Martínez-Cajas; Nitika Pant-Pai; Marina B Klein; Mark A Wainberg
Journal:  AIDS Rev       Date:  2008 Oct-Dec       Impact factor: 2.500

6.  Genotypic analysis of the protease and reverse transcriptase of non-B HIV type 1 clinical isolates from naïve and treated subjects.

Authors:  Laura Monno; Luigia Scudeller; Gaetano Brindicci; Annalisa Saracino; Grazia Punzi; Antonio Chirianni; Antonella Lagioia; Nicoletta Ladisa; Sergio Lo Caputo; Gioacchino Angarano
Journal:  Antiviral Res       Date:  2009-04-09       Impact factor: 5.970

7.  1.9 A x-ray study shows closed flap conformation in crystals of tethered HIV-1 PR.

Authors:  B Pillai; K K Kannan; M V Hosur
Journal:  Proteins       Date:  2001-04-01

8.  Estimated global distribution and regional spread of HIV-1 genetic subtypes in the year 2000.

Authors:  Saladin Osmanov; Claire Pattou; Neff Walker; Bernhard Schwardländer; Jose Esparza
Journal:  J Acquir Immune Defic Syndr       Date:  2002-02-01       Impact factor: 3.731

9.  Mutation D30N is not preferentially selected by human immunodeficiency virus type 1 subtype C in the development of resistance to nelfinavir.

Authors:  Zehava Grossman; Ellen E Paxinos; Diana Averbuch; Shlomo Maayan; Neil T Parkin; Dan Engelhard; Margalit Lorber; Valery Istomin; Yael Shaked; Ella Mendelson; Daniela Ram; Chris J Petropoulos; Jonathan M Schapiro
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

10.  Synonymous genetic polymorphisms within Brazilian human immunodeficiency virus Type 1 subtypes may influence mutational routes to drug resistance.

Authors:  Ana T Dumans; Marcelo A Soares; Elizabeth S Machado; Stéphane Hué; Rodrigo M Brindeiro; Deenan Pillay; Amilcar Tanuri
Journal:  J Infect Dis       Date:  2004-03-12       Impact factor: 5.226

View more
  13 in total

1.  Spin labeling and Double Electron-Electron Resonance (DEER) to Deconstruct Conformational Ensembles of HIV Protease.

Authors:  Thomas M Casey; Gail E Fanucci
Journal:  Methods Enzymol       Date:  2015-09-01       Impact factor: 1.600

2.  Pulsed EPR characterization of HIV-1 protease conformational sampling and inhibitor-induced population shifts.

Authors:  Zhanglong Liu; Thomas M Casey; Mandy E Blackburn; Xi Huang; Linh Pham; Ian Mitchelle S de Vera; Jeffrey D Carter; Jamie L Kear-Scott; Angelo M Veloro; Luis Galiano; Gail E Fanucci
Journal:  Phys Chem Chem Phys       Date:  2016-02-17       Impact factor: 3.676

3.  Insights into the dynamics of HIV-1 protease: a kinetic network model constructed from atomistic simulations.

Authors:  Nan-jie Deng; Weihua Zheng; Emillio Gallicchio; Ronald M Levy
Journal:  J Am Chem Soc       Date:  2011-05-25       Impact factor: 15.419

4.  HIV control is mediated in part by CD8+ T-cell targeting of specific epitopes.

Authors:  Florencia Pereyra; David Heckerman; Jonathan M Carlson; Carl Kadie; Damien Z Soghoian; Daniel Karel; Ariel Goldenthal; Oliver B Davis; Charles E DeZiel; Tienho Lin; Jian Peng; Alicja Piechocka; Mary Carrington; Bruce D Walker
Journal:  J Virol       Date:  2014-08-27       Impact factor: 5.103

5.  Conformational variation of an extreme drug resistant mutant of HIV protease.

Authors:  Chen-Hsiang Shen; Yu-Chung Chang; Johnson Agniswamy; Robert W Harrison; Irene T Weber
Journal:  J Mol Graph Model       Date:  2015-09-08       Impact factor: 2.518

6.  An insight to the molecular interactions of the FDA approved HIV PR drugs against L38L↑N↑L PR mutant.

Authors:  Zainab K Sanusi; Thavendran Govender; Glenn E M Maguire; Sibusiso B Maseko; Johnson Lin; Hendrik G Kruger; Bahareh Honarparvar
Journal:  J Comput Aided Mol Des       Date:  2018-02-03       Impact factor: 3.686

7.  Optimizing the refinement of merohedrally twinned P61 HIV-1 protease-inhibitor cocrystal structures.

Authors:  Gordon J Lockbaum; Florian Leidner; William E Royer; Nese Kurt Yilmaz; Celia A Schiffer
Journal:  Acta Crystallogr D Struct Biol       Date:  2020-03-02       Impact factor: 7.652

8.  Conformation of inhibitor-free HIV-1 protease derived from NMR spectroscopy in a weakly oriented solution.

Authors:  Julien Roche; John M Louis; Ad Bax
Journal:  Chembiochem       Date:  2014-12-02       Impact factor: 3.164

9.  Elucidating the energetics of entropically driven protein-ligand association: calculations of absolute binding free energy and entropy.

Authors:  Nan-jie Deng; Peng Zhang; Piotr Cieplak; Luhua Lai
Journal:  J Phys Chem B       Date:  2011-09-26       Impact factor: 2.991

10.  Effects of Hinge-region Natural Polymorphisms on Human Immunodeficiency Virus-Type 1 Protease Structure, Dynamics, and Drug Pressure Evolution.

Authors:  Zhanglong Liu; Xi Huang; Lingna Hu; Linh Pham; Katye M Poole; Yan Tang; Brian P Mahon; Wenxing Tang; Kunhua Li; Nathan E Goldfarb; Ben M Dunn; Robert McKenna; Gail E Fanucci
Journal:  J Biol Chem       Date:  2016-08-30       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.